Evidence map›Paper›PMID 39269182›Full record

ArticleMicrobiology spectrum2024

Akihiro Ochi, Yuji Toya, Mikako Sengoku, Seiichiro Tsuchiya, Daiki Kishi, Takanori Ueno

Abstract readEvaluation Study
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Research progress on diagnostic techniques for differentFrontiers in cellular and infection microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Akihiro OchiEquine Research Institute, Japan Racing Association, Shimotsuke, Tochigi, Japan.ORCID 0000-0002-8972-3090
Yuji ToyaCell Technology, Engineering 1, Sysmex Corporation, Kobe, Hyogo, Japan.
Mikako SengokuCell Technology, Engineering 1, Sysmex Corporation, Kobe, Hyogo, Japan.
Seiichiro TsuchiyaCell Technology, Engineering 1, Sysmex Corporation, Kobe, Hyogo, Japan.
Daiki KishiEquine Research Institute, Japan Racing Association, Shimotsuke, Tochigi, Japan.
Takanori UenoEquine Research Institute, Japan Racing Association, Shimotsuke, Tochigi, Japan.

Funding

Japan Racing Association (JRA) 2020-3272-02
6 · The paper itself

Abstract

Equine piroplasmosis (EP) is a protozoal disease affecting equids, caused by IMPORTANCE: In this study, we demonstrated that the automated hematology analyzer, XN-31, can detect red blood cells infected with

Indexed as

BabesiaBabesiosisHorse DiseasesTheileriaAnimalsErythrocytesHematologic TestsHematologyHorsesLimit of DetectionSensitivity and Specificityequine piroplasmosishematology analyzerhorserapid diagnosisXN-31

Identifiers

PMID39269182
PMCPMC11448420

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.